Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Y Chan

Showing results (221-230 of 430) with videos related to

Pageof 43
Sort By:
Alimentary Pharmacology & Therapeutics|November 4, 2015
Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis BG L-H Wong, H L-Y Chan, H-Y Chan, et al.
Biochemical and Biophysical Research Communications|August 5, 2008
A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activitiesQingming Dong, Henry L Y Chan, Zheng Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 14, 2017
Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of FibrosisSuzanne E Mahady, Petra Macaskill, Jonathan C Craig, et al.
Plos One|March 22, 2014
A robust parameter estimation method for estimating disease burden of respiratory virusesKing Pan Chan, Chit Ming Wong, Susan S S Chiu, et al.
Hepatology (Baltimore, Md.)|December 25, 2007
Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivoBo Shen, Jun Yu, Shiyan Wang, et al.
Journal of Viral Hepatitis|May 16, 2002
Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patientsJoseph J-Y Sung, H L-Y Chan, M L Wong, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapyA S L Cheng, H L Y Chan, N W Y Leung, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2007
Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis BH L-Y Chan, V W-S Wong, C-H Tse, et al.
Journal of Hepatology|July 19, 2022
Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinionGeorge V Papatheodoridis, Vasileios Lekakis, Thodoris Voulgaris, et al.
Journal of Viral Hepatitis|August 19, 2014
The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxilY Liu, X Li, S Xin, et al.
Pageof 43

Showing results (221-230 of 430) with videos related to

Sort By:
Pageof 43
Alimentary Pharmacology & Therapeutics|November 4, 2015
Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis BG L-H Wong, H L-Y Chan, H-Y Chan, et al.
Biochemical and Biophysical Research Communications|August 5, 2008
A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activitiesQingming Dong, Henry L Y Chan, Zheng Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 14, 2017
Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of FibrosisSuzanne E Mahady, Petra Macaskill, Jonathan C Craig, et al.
Plos One|March 22, 2014
A robust parameter estimation method for estimating disease burden of respiratory virusesKing Pan Chan, Chit Ming Wong, Susan S S Chiu, et al.
Hepatology (Baltimore, Md.)|December 25, 2007
Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivoBo Shen, Jun Yu, Shiyan Wang, et al.
Journal of Viral Hepatitis|May 16, 2002
Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patientsJoseph J-Y Sung, H L-Y Chan, M L Wong, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapyA S L Cheng, H L Y Chan, N W Y Leung, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2007
Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis BH L-Y Chan, V W-S Wong, C-H Tse, et al.
Journal of Hepatology|July 19, 2022
Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinionGeorge V Papatheodoridis, Vasileios Lekakis, Thodoris Voulgaris, et al.
Journal of Viral Hepatitis|August 19, 2014
The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxilY Liu, X Li, S Xin, et al.
Pageof 43